BioSpace News Archive

The shifting regulatory landscape and growing demand for quicker approval processes are positively influencing the progress of the global medical device regulatory affairs market.

The demand within the global market for lateral flow diagnostic tests has been rising on account of advancements in the field of healthcare diagnostics, finds Transparency Market Research.

Guardant Health, Inc., a leading precision oncology company, filed a lawsuit against Natera, Inc. for false advertising, unfair competition, and unlawful trade practices, relating to misleading statements Natera has made about its own products and the performance of Guardant Health’s new oncology test, Guardant Reveal™.

Case presentations highlight ACTIVA Presto, the first light-cure restorative designed to mimic the properties of natural teeth

Zentalis Pharmaceuticals, Inc. announced that Anthony Sun, MD, Chairman and Chief Executive Officer of Zentalis and Melissa Epperly, MBA, Chief Financial Officer of Zentalis, will participate in a fireside chat at the Jefferies Virtual Healthcare Conference on Friday, June 4, 2021 at 2:30 p.m. ET.

Amicus Therapeutics announced that members of the Amicus senior leadership team will participate in a fireside chat at the Goldman Sachs 42nd Annual Global Healthcare Conference, being held virtually on Wednesday, June 9, 2021 at 5:30 p.m. E.T.

Online event to include a live reading by Children’s Author, Ariana Feiner, whose short film documentary, A Story of Courage, has won 24 international awards

In partnership with the University of St. Francis’ Leach College of Nursing, KODOCARE has been at the forefront of the greater Chicagoland area vaccination efforts since vaccine administration began in January.

SOFIE, an established Radiopharmaceutical Contract Manufacturing Organization and GMP radiopharmacy network, will be commercially manufacturing and distributing PYLARIFY® injection, an F 18-labeled prostate-specific membrane antigen targeted positron emission tomography imaging agent.

Spectrum Pharmaceuticals, a biopharmaceutical company focused on novel and targeted oncology therapies, announced a poster presentation on poziotinib CNS activity in patients with NSCLC with EGFR or HER2 exon 20 mutations.